Noémie Girard

ORCID: 0000-0001-5402-2959
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Lung Cancer Research Studies
  • Breast Lesions and Carcinomas
  • Gastric Cancer Management and Outcomes
  • Global Cancer Incidence and Screening
  • Cancer Immunotherapy and Biomarkers
  • Multiple and Secondary Primary Cancers
  • HER2/EGFR in Cancer Research
  • Sarcoma Diagnosis and Treatment
  • Cancer Risks and Factors
  • Ovarian cancer diagnosis and treatment
  • Advanced Radiotherapy Techniques
  • Nosocomial Infections in ICU
  • MRI in cancer diagnosis
  • Economic and Financial Impacts of Cancer
  • Cancer Genomics and Diagnostics
  • Psychoanalysis and Psychopathology Research
  • Cardiac, Anesthesia and Surgical Outcomes
  • Radiomics and Machine Learning in Medical Imaging
  • Respiratory Support and Mechanisms
  • Bladder and Urothelial Cancer Treatments
  • Colorectal Cancer Treatments and Studies
  • COVID-19 and healthcare impacts

Institut Curie
2018-2025

Institut Jean Godinot
2023-2025

Université de Montréal
2024

Université Paris Cité
2017-2024

Université de Versailles Saint-Quentin-en-Yvelines
2023-2024

Institut du Thorax
2018-2024

Université Paris-Saclay
2024

Université Paris Sciences et Lettres
2021-2022

CHU Dijon Bourgogne
2020-2021

Hôpital Antoine-Béclère
2017

•The PACIFIC trial established durvalumab after CRT as a global standard of care for unresectable stage III NSCLC.•PACIFIC-R is an observational study cohort patients who received through early access program.•PACIFIC-R data are broadly consistent with outcomes from and real-world studies the regimen.•Encouraging were observed across subgroups, including among sCRT PD-L1 TCs <1%.•These support continued use regimen NSCLC. BackgroundBased on findings trial, consolidation following...

10.1016/j.esmoop.2024.103464 article EN cc-by-nc-nd ESMO Open 2024-06-01

Background Ultrafast dynamic contrast-enhanced (DCE) MRI parameters are associated with breast cancer aggressiveness. However, the role of these as predictive biomarkers for pathologic response after neoadjuvant chemotherapy (NAC) has been poorly investigated. Purpose To assess whether semiquantitative perfusion calculated at initial ultrafast DCE early prediction NAC in participants cancer. Materials and Methods This prospective single-center study included consecutive women nonmetastatic...

10.1148/radiol.220389 article EN Radiology 2022-07-26

Wire guided localization is widely used as the standard method of pre-operative breast lesions. The aim was to assess outcomes following introduction a novel non-wire guided, magnetic surgical marker navigation system. A prospective study between May 2022 and June 2023 established data base first 200 procedures performed using Sirius Pintuition GPS Detect marker. primary outcome measures were successful excision target lesion retrieval excised retrieved in all procedures. In 17 (8.5% total...

10.1038/s41598-025-88430-5 article EN cc-by-nc-nd Scientific Reports 2025-02-10

Background Perfusion-related complications remain the most common concern in DIEP flap breast reconstruction. Indocyanine green-based fluorescence angiography can be used for real-time intra operative assessment of perfusion. The SPY Elite system is widely device this setting. main objective was to describe use SPY-Q proprietary software perform qualitative and quantitative analysis Methods This retrospective cohort study performed at Curie Institute between 2013 2017. We included patients...

10.1371/journal.pone.0217698 article EN cc-by PLoS ONE 2019-06-25

Abstract Background The main objective of this study was to undertake an exhaustive investigation sex-related differences in cancer surgery. Methods This observational used data from the French national health insurance system database covering 98.8% population. Patients diagnosed with non-sex-specific solid invasive cancers between January 2018 and December 2019 were included. outcomes likelihood undergoing surgery, type oncological surgery performed, associated 30-, 60-, 90-day...

10.1093/bjs/znae179 article EN cc-by British journal of surgery 2024-08-01

Gender-based disparities in health-care are common and can affect access to care. We aimed investigate the impact of gender socio-environmental indicators on oncology France.Using national health insurance system database France, we identified patients (aged ≥18 years) who were diagnosed with solid invasive cancers between 1st January 2018 31st December 2019. ensured that only incident cases by excluding an existing cancer diagnosis 2016 2017; skin other than melanoma also excluded....

10.1016/j.eclinm.2023.102298 article EN cc-by-nc-nd EClinicalMedicine 2023-11-01

Introduction: The three different breast cancer subtypes (Luminal, HER2-positive, and triple negative (TNBCs) display natural history sensitivity to treatment, but little is known about whether residual axillary disease after neoadjuvant chemotherapy (NAC) carries a prognostic value by BC subtype. Methods: We retrospectively evaluated the involvement (0, 1 3 positive nodes, ≥4 nodes) on surgical specimens from cohort of T1-T3NxM0 patients treated with NAC between 2002 2012. analyzed...

10.3390/cancers13020171 article EN Cancers 2021-01-06

&lt;b&gt;&lt;i&gt;Objective:&lt;/i&gt;&lt;/b&gt; Fetal megacystis has a poor prognosis. During the first trimester, it is frequently associated with chromosomal abnormalities or multiple malformations, but can also be isolated and resolve spontaneously. In this study, our main objective was to determine fetal pediatric prognosis in particular situation. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; This retrospective multicenter study. We describe cases referred medicine centers previously...

10.1159/000458522 article EN Fetal Diagnosis and Therapy 2017-01-01

Breast cancer (BC) is the most commonly diagnosed type of and leading cause deaths in women. Smoking principal modifiable risk factor for cancers has a negative influence on long-term survival. We conducted retrospective study consecutive BC survivors seen at follow-up consultations between 3 June 30 October 2019 Institut Curie, Paris, France. behaviors were evaluated prospectively via interviewer-administered questionnaires. The aim this was to describe smoking-related patient care...

10.3390/cancers13102423 article EN Cancers 2021-05-17

The treatment of breast cancer, the leading cause cancer and mortality among women worldwide, is mainly on basis surgery. In this study, we describe use a medical image visualization tool virtual reality (VR), entitled DIVA, in context tumor localization surgeons. aim study was to evaluate speed accuracy surgeons using DIVA for analysis magnetic resonance (MRI) scans relative standard slice-based tools.

10.1200/cci.21.00048 article EN JCO Clinical Cancer Informatics 2021-11-12

Survival disparities persist in ovarian cancer and may be linked to the environments which patients live. The main objective of this study was analyze global impact area residence on overall survival. data were obtained from Surveillance, Epidemiology End Results (SEER) database. We included all with epithelial cancers diagnosed between 2010 2016. areas analyzed by hierarchical clustering principal components group similar counties. A multivariable Cox proportional hazards model then fitted...

10.3390/cancers14235987 article EN Cancers 2022-12-04

<title>Abstract</title> Wire guided localization is widely used as the standard method of pre-operative breast lesions. The aim was to assess outcomes following introduction a novel non wire guided, magnetic surgical marker navigation system. A prospective study between May 2022 and June 2023 established data base first 200 procedures performed using Sirius Pintuition GPS Detect marker. primary outcome measures were successful excision target lesion retrieval excised retrieved in all...

10.21203/rs.3.rs-4516185/v1 preprint EN cc-by Research Square (Research Square) 2024-06-25
Coming Soon ...